Incyte Switzerland — PP&E (Net) decreased by 1.6% to $304.82M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.8%, from $282.70M to $304.82M.
An increase suggests capital expansion or investment in regional infrastructure, while a decrease may indicate asset depreciation, divestment, or a shift in operational focus away from the region.
This metric represents the net book value of tangible assets, such as manufacturing facilities, laboratories, and specia...
Peers in the pharmaceutical industry typically report similar regional asset bases, which are compared based on the intensity of local manufacturing and R&D footprint relative to total global assets.
incy_segment_switzerland_property_and_equipment_net| Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $303.90M | $277.62M | $282.70M | $310.21M | $308.11M | $309.80M | $304.82M |
| QoQ Change | — | -8.6% | +1.8% | +9.7% | -0.7% | +0.6% | -1.6% |
| YoY Change | — | -8.6% | — | — | — | +11.6% | +7.8% |